• Teofarma is a private, non-listed pharmaceutical group, established in the late 80’s in Pavia which acquires the property of mature, established assets, based on full dossier. Teofarma markets originator brands, not generic products.

• About 300 Marketing Authorizations in several therapeutic areas (ATCs) were sold by Multinational Companies to Teofarma.

• Teofarma brands are in specialty-care, critical-care and rare diseases; some of them are prescribed also by physicians in primary care. • Corporate sales are made out for: 90% in Europe, 7% in Middle-East and Africa, 2% in Australia and 1% in Latin America.